IPS - Clinolipid
Biological Integrated Pharmacy Solutions
General payments
$26,343
Research payments
$0
Through program year 2024, $26,343 in general payments and $0 in research payments were reported against IPS - Clinolipid (Integrated Pharmacy Solutions).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $8,330 | 8 |
| 2020 | General | $17,940 | 4 |
| 2019 | General | $73 | 4 |
Breakdown
Each share is of general payments naming this product in 2024.
Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2024 where a state was reported.
Records
16 generalEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.